FDA Staff Backs Injection to Reduce Double ChinFDA Staff Backs Injection to Reduce Double Chin

An injection for "double chin" reduction developed by Kythera Biopharmaceuticals Inc cleared the first hurdle toward approval as U.S. Food and Drug Administration staff concluded the drug's benefits outweighed its risks. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news